Endpoints Newsnews

Tender offer for Recordati; Sobi's gout drug passes Phase 3 test

Friday, May 22, 2026ENDPOINTSView original
Plus, news about Immunovant and Retro Biosciences. ๐Ÿ’ธ CVC and GBL launch tender offer for Recordati: CVC Capital Partners and Groupe Bruxelles Lambert (GBL), a Belgian investment holding company, launched their cash voluntary tender

Read the full article on the original site.

Read Full Article